CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Balance (in shares) at Jun. 30, 2023			2,277,828
Balance at Jun. 30, 2023		$ (36,730)	$ 114	$ 66,764	$ 9,023	$ (112,631)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		2,191				2,191
Foreign currency translation		3			3
Stock-based compensation		959		959
Net restricted stock activity (in shares)			1,622
Net restricted stock activity		(13)		(13)
Balance (in shares) at Dec. 31, 2023			2,279,450
Balance at Dec. 31, 2023		(33,590)	$ 114	67,710	9,026	(110,440)
Balance (in shares) at Sep. 30, 2023			2,278,479
Balance at Sep. 30, 2023		(35,264)	$ 114	67,325	8,734	(111,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		997				997
Foreign currency translation		292			292
Stock-based compensation		392		392
Net restricted stock activity (in shares)			971
Net restricted stock activity		(7)		(7)
Balance (in shares) at Dec. 31, 2023			2,279,450
Balance at Dec. 31, 2023		$ (33,590)	$ 114	67,710	9,026	(110,440)
Balance (in shares) at Jun. 30, 2024		2,279,948	2,279,948
Balance at Jun. 30, 2024		$ 56,787	$ 114	69,660	8,584	(21,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		6,792				6,792
Foreign currency translation		(452)			(452)
Stock-based compensation		665		665
Net restricted stock activity (in shares)			15,481
Net restricted stock activity		(74)	$ 1	(75)
Common stock issued in connection with Alline acquisition (Note 13) (in shares)	[1]		140,550
Common stock issued in connection with Alline acquisition (Note 13)	[1]	$ 3,000	$ 7	2,993		0
Balance (in shares) at Dec. 31, 2024		2,435,979	2,435,979
Balance at Dec. 31, 2024		$ 66,718	$ 122	73,243	8,132	(14,779)
Balance (in shares) at Sep. 30, 2024			2,282,395
Balance at Sep. 30, 2024		56,398	$ 114	69,972	8,736	(22,424)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		7,645				7,645
Foreign currency translation		(604)			(604)
Stock-based compensation		330		330
Net restricted stock activity (in shares)			13,034
Net restricted stock activity		(51)	$ 1	(52)
Common stock issued in connection with Alline acquisition (Note 13) (in shares)	[1]		140,550
Common stock issued in connection with Alline acquisition (Note 13)	[1]	$ 3,000	$ 7	2,993		0
Balance (in shares) at Dec. 31, 2024		2,435,979	2,435,979
Balance at Dec. 31, 2024		$ 66,718	$ 122	$ 73,243	$ 8,132	$ (14,779)

[1] This activity represents the common stock issued in connection with the Alline acquisition on December 19, 2024. See Note 13 for additional details.